Suggested Readings

Nobel Laureate Dr. Jennifer Doudna spoke at Fred Hutch Cancer Center in Seattle about strategies to improve CRISPR gene editing and delivery to help make CRISPR-based gene therapies cheaper and easier to access.

Nobel laureate and CRISPR pioneer Jennifer A. Doudna, PhD, spoke at Fred Hutch Cancer Center, sharing advancements in gene-editing therapies. Her lab is refining CRISPR to improve efficiency, affordability, and delivery methods, such as miniEDVs for in-body editing. Doudna advocates for ethical policies and wider accessibility of therapies like Casgevy, a CRISPR-based sickle cell treatment. Her work emphasizes collaboration across science, regulation, and manufacturing.

Topics: /

Ruth Lehmann argues that intellectual freedom for scientists unconstrained by commercial interests fuels unexpected discoveries.

Ruth Lehmann discusses 25 years of developmental biology progress, emphasizing curiosity-driven research’s importance. She advocates for robust funding, highlighting basic science’s role in healthcare breakthroughs and stressing the need for intellectual freedom in scientific exploration for societal progress.

Lawrence M. Krauss on the greatness of Charles Darwin’s first book. 

A great read at Quillette by Lawrence M. Krauss on Charles Darwin’s first book “The Voyage of the Beagle” arguing that it is a literary masterpiece, as well as a scientific one.

Black holes are simpler than forests and science has its limits

Martin Rees , UK based astronomer Royal and a fellow of Trinity College Cambridge, has written an article on black holes arguing that they are simpler than forests yet our brains we’ll reach the limits when we try to explain them. Read the article on AEON’s website.

Ravenous: Otto Warburg, the Nazis, and the Search for the Cancer-Diet Connection

Explore the remarkable narrative of a scientific prodigy during the Nazi era who unraveled the process of cancer cell consumption, and its implications for our approach to the disease. Otto Warburg, a Nobel laureate and a relative of the renowned Warburg finance family, commanded significant respect as a prominent biochemist in the 20th century.

Nobel Laureate Dr. Jennifer Doudna spoke at Fred Hutch Cancer Center in Seattle about strategies to improve CRISPR gene editing and delivery to help make CRISPR-based gene therapies cheaper and easier to access.

Nobel laureate and CRISPR pioneer Jennifer A. Doudna, PhD, spoke at Fred Hutch Cancer Center, sharing advancements in gene-editing therapies. Her lab is refining CRISPR to improve efficiency, affordability, and delivery methods, such as miniEDVs for in-body editing. Doudna advocates for ethical policies and wider accessibility of therapies like Casgevy, a CRISPR-based sickle cell treatment. Her work emphasizes collaboration across science, regulation, and manufacturing.

Topics: /

Ruth Lehmann argues that intellectual freedom for scientists unconstrained by commercial interests fuels unexpected discoveries.

Ruth Lehmann discusses 25 years of developmental biology progress, emphasizing curiosity-driven research’s importance. She advocates for robust funding, highlighting basic science’s role in healthcare breakthroughs and stressing the need for intellectual freedom in scientific exploration for societal progress.

Lawrence M. Krauss on the greatness of Charles Darwin’s first book. 

A great read at Quillette by Lawrence M. Krauss on Charles Darwin’s first book “The Voyage of the Beagle” arguing that it is a literary masterpiece, as well as a scientific one.

Black holes are simpler than forests and science has its limits

Martin Rees , UK based astronomer Royal and a fellow of Trinity College Cambridge, has written an article on black holes arguing that they are simpler than forests yet our brains we’ll reach the limits when we try to explain them. Read the article on AEON’s website.

Ravenous: Otto Warburg, the Nazis, and the Search for the Cancer-Diet Connection

Explore the remarkable narrative of a scientific prodigy during the Nazi era who unraveled the process of cancer cell consumption, and its implications for our approach to the disease. Otto Warburg, a Nobel laureate and a relative of the renowned Warburg finance family, commanded significant respect as a prominent biochemist in the 20th century.

Scroll to Top